SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
ANTIRETROVIRAL THERAPY: INSIGHTS FROM OBSERVATIONAL STUDIES
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
7 of
7
|
IMPACT OF ANTIRETROVIRAL REGIMENS ON MORTALITY IN PATIENTS WITH ADVANCED HIV DISEASE (ABSTRACT
405)
Joaquin Burgos-Cibrian
Hospital University Vall d'Hebron, Barcelona, BARCELONA, Spain
EFFECTIVENESS OF RECOMMENDED 3-DRUG REGIMENS FOR TREATING ADVANCED HIV INFECTION (ABSTRACT
406)
Karam Mounzer
Jonathan Lax Center, Philadelphia, USA
BLIP INCIDENCE IN DOLUTEGRAVIR- OR EFAVIRENZ-BASED ART DURING ACUTE HIV INFECTION (ABSTRACT
407)
Bharat Nandakumar
University of Milan, Milan, Italy
HMMCGAG ASSAY DETECTS HIGH VIREMIA RATES ON ART STARTED DURING ACUTE HIV INFECTION (ABSTRACT
408)
Donn J Colby
Henry M. Jackson Foundation, Seattle, WA, USA
CURRENT ANTIRETROVIRAL TREATMENT AMONG PEOPLE WITH HIV IN CARE IN THE US (2018-2019) (ABSTRACT
409)
Jimmy Ma
University of Washington, Seattle, WA, USA
CHARACTERIZING FIRST VIRAL FAILURES AMONG ANTIRETROVIRAL THERAPY INITIATORS IN THE US (ABSTRACT
410)
Thibaut Davy-Mendez
University of California San Francisco, San Francisco, CA, USA
SECOND ANTIRETROVIRAL THERAPY REGIMEN IN VIREMIC PEOPLE WITH HIV IN THE US, 2008-2018 (ABSTRACT
411)
Thibaut Davy-Mendez
University of California San Francisco, San Francisco, CA, USA
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
7 of
7
|